BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -56.32 Million DKK | 25.81% |
| 2022 | -75.92 Million DKK | -32.93% |
| 2021 | -57.11 Million DKK | 7.23% |
| 2020 | -61.56 Million DKK | 11.6% |
| 2019 | -69.64 Million DKK | -83.04% |
| 2018 | -38.04 Million DKK | -18.0% |
| 2017 | -32.24 Million DKK | -41.42% |
| 2016 | -22.8 Million DKK | -112.45% |
| 2015 | -10.73 Million DKK | 16.97% |
| 2014 | -12.92 Million DKK | 37.32% |
| 2013 | -20.62 Million DKK | -40.29% |
| 2012 | -14.7 Million DKK | 0.93% |
| 2011 | -14.83 Million DKK | -4.44% |
| 2010 | -14.2 Million DKK | 10.95% |
| 2009 | -15.95 Million DKK | -11.85% |
| 2008 | -14.26 Million DKK | 0.0% |
| 2007 | -14.26 Million DKK | 9.3% |
| 2006 | -15.72 Million DKK | -5.15% |
| 2005 | -14.95 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -15.84 Million DKK | -16.9% |
| 2024 Q1 | -13.55 Million DKK | -22.97% |
| 2023 Q2 | -19.64 Million DKK | -22.35% |
| 2023 Q4 | -11.02 Million DKK | -14.83% |
| 2023 Q3 | -9.59 Million DKK | 51.15% |
| 2023 Q1 | -16.06 Million DKK | 35.57% |
| 2023 FY | -56.32 Million DKK | 25.81% |
| 2022 Q4 | -24.92 Million DKK | -47.69% |
| 2022 FY | -75.92 Million DKK | -32.93% |
| 2022 Q1 | -17.03 Million DKK | -1.72% |
| 2022 Q2 | -17.09 Million DKK | -0.36% |
| 2022 Q3 | -16.87 Million DKK | 1.25% |
| 2021 Q4 | -16.74 Million DKK | -47.07% |
| 2021 FY | -57.11 Million DKK | 7.23% |
| 2021 Q1 | -15.36 Million DKK | -14.49% |
| 2021 Q2 | -13.62 Million DKK | 11.33% |
| 2021 Q3 | -11.38 Million DKK | 16.44% |
| 2020 Q3 | -17.34 Million DKK | -12.5% |
| 2020 Q1 | -15.37 Million DKK | 2.41% |
| 2020 FY | -61.56 Million DKK | 11.6% |
| 2020 Q2 | -15.42 Million DKK | -0.32% |
| 2020 Q4 | -13.42 Million DKK | 22.65% |
| 2019 Q2 | -15.75 Million DKK | 4.42% |
| 2019 Q4 | -15.75 Million DKK | 27.27% |
| 2019 Q3 | -21.65 Million DKK | -37.47% |
| 2019 FY | -69.64 Million DKK | -83.04% |
| 2019 Q1 | -16.48 Million DKK | -121.77% |
| 2018 Q4 | -7.43 Million DKK | 31.43% |
| 2018 FY | -38.04 Million DKK | -18.0% |
| 2018 Q1 | -11.22 Million DKK | -61.11% |
| 2018 Q2 | -8.55 Million DKK | 23.76% |
| 2018 Q3 | -10.83 Million DKK | -26.7% |
| 2017 Q1 | -8.54 Million DKK | -115.07% |
| 2017 Q4 | -6.96 Million DKK | 23.3% |
| 2017 Q3 | -9.08 Million DKK | -18.72% |
| 2017 FY | -32.24 Million DKK | -41.42% |
| 2017 Q2 | -7.64 Million DKK | 10.53% |
| 2016 Q4 | -3.97 Million DKK | 40.33% |
| 2016 FY | -22.8 Million DKK | -112.45% |
| 2016 Q1 | -5.08 Million DKK | -174.18% |
| 2016 Q2 | -7.07 Million DKK | -39.17% |
| 2016 Q3 | -6.66 Million DKK | 5.88% |
| 2015 Q1 | -3.97 Million DKK | -80.69% |
| 2015 Q3 | -1.71 Million DKK | 47.72% |
| 2015 Q4 | -1.85 Million DKK | -8.48% |
| 2015 Q2 | -3.27 Million DKK | 17.75% |
| 2015 FY | -10.73 Million DKK | 16.97% |
| 2014 Q1 | -3.61 Million DKK | -4.18% |
| 2014 FY | -12.92 Million DKK | 37.32% |
| 2014 Q3 | -2.46 Million DKK | 46.87% |
| 2014 Q4 | -2.2 Million DKK | 10.82% |
| 2014 Q2 | -4.64 Million DKK | -28.6% |
| 2013 Q1 | -5.63 Million DKK | -76.24% |
| 2013 FY | -20.62 Million DKK | -40.29% |
| 2013 Q3 | -6.4 Million DKK | -24.88% |
| 2013 Q4 | -3.46 Million DKK | 45.83% |
| 2013 Q2 | -5.12 Million DKK | 8.99% |
| 2012 Q4 | -3.19 Million DKK | -0.09% |
| 2012 Q2 | -4.11 Million DKK | 2.02% |
| 2012 Q1 | -4.19 Million DKK | -0.86% |
| 2012 Q3 | -3.19 Million DKK | 22.41% |
| 2012 FY | -14.7 Million DKK | 0.93% |
| 2011 Q1 | -1.76 Million DKK | 60.17% |
| 2011 Q3 | -2.13 Million DKK | 61.21% |
| 2011 Q4 | -4.16 Million DKK | -95.08% |
| 2011 FY | -14.83 Million DKK | -4.44% |
| 2011 Q2 | -5.5 Million DKK | -211.49% |
| 2010 Q2 | -2.99 Million DKK | 13.83% |
| 2010 Q4 | -4.43 Million DKK | -33.92% |
| 2010 Q3 | -3.31 Million DKK | -10.7% |
| 2010 FY | -14.2 Million DKK | 10.95% |
| 2010 Q1 | -3.47 Million DKK | 12.5% |
| 2009 Q3 | -3.53 Million DKK | 27.09% |
| 2009 Q1 | -3.61 Million DKK | 0.0% |
| 2009 FY | -15.95 Million DKK | -11.85% |
| 2009 Q4 | -3.96 Million DKK | -12.35% |
| 2009 Q2 | -4.84 Million DKK | -34.04% |
| 2008 FY | -14.26 Million DKK | 0.0% |
| 2007 FY | -14.26 Million DKK | 9.3% |
| 2006 FY | -15.72 Million DKK | -5.15% |
| 2005 FY | -14.95 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -3894.894% |
| Arrayit Corporation | -3.31 Million USD | -1598.881% |
| Atlantic International Corp. | -5.62 Million USD | -900.926% |
| Biocept, Inc. | -32.08 Million USD | -75.548% |
| Bioqual, Inc. | 483.48 Thousand USD | 11750.51% |
| CardioGenics Holdings Inc | -1.91 Million USD | -2839.378% |
| DermTech, Inc. | -100.88 Million USD | 44.168% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 102.782% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | -160.844% |
| iMD Companies, Inc. | -200.63 Thousand USD | -27974.722% |
| IDenta Corp. | 14.64 Thousand USD | 384749.003% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 7123.441% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 145691.77% |
| InVitro International | 1553.00 USD | 3627144.43% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -555.587% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -96830.066% |
| Medical Imaging Corp. | -3.02 Million USD | -1763.3% |
| NovelStem International Corp. | -4.18 Million USD | -1245.211% |
| Optigenex Inc. | -2.89 Million USD | -1843.846% |
| PharmChem, Inc. | 845.1 Thousand USD | 6765.231% |
| Proteome Sciences plc | -2.44 Million USD | -2205.69% |
| Response Genetics, Inc | -20.18 Million USD | -179.073% |
| Rennova Health, Inc. | -3.29 Million USD | -1610.509% |
| RushNet, Inc. | -607.02 Thousand USD | -9179.308% |
| ScreenPro Security Inc. | -2.24 Million USD | -2404.839% |
| Stella Diagnostics Inc. | -5.7 Million USD | -886.924% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -393.44% |
| Todos Medical Ltd. | -24.99 Million USD | -125.366% |